MedTrace Logo

Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)

NCT00512330 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2008-08-06

No results posted yet for this study

Summary

In children, it remains quite difficult even in developed countries, to prove a diagnosis of Tuberculosis (TB). New means for diagnosis of this disease are currently being researched. One candidate test is Lipoarabinomannan ELISA from Urine, which has shown good sensitivity of up to 80% in adults.

Our study aims to evaluate this test in the diagnosis of children with TB.

Conditions

Sponsors & Collaborators

  • Our Lady of Mount Carmel Community Hospital, Kapiri, Malawi

    collaborator UNKNOWN

  • Ministry of Health and Population, Malawi

    collaborator OTHER_GOV

  • Mbeya Medical Research Programme, Mbeya, Tanzania

    collaborator UNKNOWN

  • Unterstützerkreis Missionskrankenhaus Kapiri e.V., Munich, Germany

    collaborator UNKNOWN

  • Foerderverein AIDS im Kindesalter in Bonn e.V., Bonn, Germany

    collaborator UNKNOWN

  • Children's Medical Hospital, University of Bonn, Germany

    collaborator OTHER

  • University Hospital, Bonn

    lead OTHER

Principal Investigators

  • Norbert Heinrich, MD · University of Bonn

  • John Chimphamba, Clinical Officer · Our Lady of Mount Carmel Hospital, Kapiri

  • Andreas Mueller, PD Dr med. · University of Bonn

Eligibility

Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Completion
2008-08-31

Countries

  • Malawi

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00512330 on ClinicalTrials.gov